Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Staphylococcus Aureus Network Adaptive Platform Trial

NCT05137119 is registered in ClinicalTrials.gov with University of Melbourne as lead sponsor.

NCT NCT05137119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05137119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Staphylococcus Aureus Network Adaptive Platform Trial
Lead sponsor
University of Melbourne
Phase
Phase 4
Overall status
Recruiting
Start date
February 16, 2022
Completion date
December 1, 2028
Enrollment
8,000 (estimated)
Sites
161

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcus aureus bacteremia